Remimazolam for Bronchoscopy in High-Risk Patients
Remimazolam for Bronchoscopy in High-Risk Patients
Recruiting · NCT07395596 · Registry updated 2026-02-24Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Remimazolam for Bronchoscopy in High-Risk Patients | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Hypoxia, Infections, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Respiratory, bacterial infectious disease, gram-positive bacterial infections, lung disorder, mycobacterial infectious disease, pulmonary tuberculosis, respiratory system disorder, respiratory tract infectious disorder, tuberculosis | Recruiting | Phase 4 | 2026-02-24 | NCT07395596 |
4 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Shaoxing City First People's Hospital | Shaoxing | China | 1 |
| The First Affliated Hospital, Zhejiang University School Of Medicine | Hangzhou | China | 1 |